Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Wingerchuk · SciRah

Researcher profile · Semantic Scholar

D. Wingerchuk

Share profile

D. Wingerchuk — researcher profile on SciRah

h-index: 70
Works: 346
Citations: 35K

Most-cited papers

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.
B. Cree, J. Bennett, H. Kim, B. Weinshenker +17 more
2019The Lancet621 citations
Semantic Scholar
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.
S. Pittock, A. Berthele, K. Fujihara, H. Kim +11 more
2019New England Journal of Medicine451 citations Open access
Semantic Scholar
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
J. Y. Hor, N. Asgari, I. Nakashima, S. Broadley +12 more
2020Frontiers in Neurology362 citations Open access
Semantic Scholar
Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder
John J. Chen, E. Flanagan, M. Bhatti, Jiraporn Jitprapaikulsan +28 more
2020Neurology185 citations Open access
Semantic Scholar
Treatment of MOG antibody associated disorders: results of an international survey
D. Whittam, V. Karthikeayan, E. Gibbons, R. Kneen +60 more
2020Journal of Neurology134 citations Open access
Semantic Scholar
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker
O. Aktas, Michael A Smith, W. Rees, J. Bennett +15 more
2021Annals of Neurology132 citations Open access
Semantic Scholar
Neuromyelitis Optica Spectrum Disorder.
D. Wingerchuk, C. Lucchinetti
2022New England Journal of Medicine111 citations
Semantic Scholar
Long‐Term Safety and Efficacy of Eculizumab in Aquaporin‐4 IgG‐Positive NMOSD
D. Wingerchuk, K. Fujihara, Jacqueline Palace, A. Berthele +10 more
2021Annals of Neurology84 citations Open access
Semantic Scholar
Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and review.
P. Elsbernd, W. R. Hoffman, J. Carter, D. Wingerchuk
2020Multiple Sclerosis and Related Disorders84 citations
Semantic Scholar
Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension
S. Pittock, K. Fujihara, Jacqueline A Palace, A. Berthele +9 more
2021Multiple Sclerosis65 citations Open access
Semantic Scholar
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
B. Cree, Ho Jin Kim, B. Weinshenker, S. Pittock +14 more
2024Lancet Neurology52 citations
Semantic Scholar
Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders
Vyanka Redenbaugh, Mayra Montalvo, Elia Sechi, Marina Buciuc +11 more
2021Multiple Sclerosis Journal - Experimental, Translational and Clinical47 citations Open access
Semantic Scholar
Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder
O. Aktas, H. Hartung, Michael A Smith, W. Rees +14 more
2023Journal of Neurology Neurosurgery & Psychiatry46 citations Open access
Semantic Scholar
Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial
J. Bennett, O. Aktas, W. Rees, Michael A Smith +17 more
2022EBioMedicine43 citations Open access
Semantic Scholar
CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies
Hannah Zhao-Fleming, Cristina Valencia Sanchez, Elia Sechi, Jery D Inbarasu +11 more
2021Neurology39 citations Open access
Semantic Scholar
Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder
R. Marignier, J. Bennett, H. Kim, B. Weinshenker +18 more
2021Neurology: Neuroimmunology & Neuroinflammation35 citations Open access
Semantic Scholar
AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
R. Marignier, S. Pittock, F. Paul, H. Kim +16 more
2021Multiple Sclerosis and Related Disorders35 citations Open access
Semantic Scholar
Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial.
Jacqueline Palace, D. Wingerchuk, K. Fujihara, A. Berthele +13 more
2020Multiple Sclerosis and Related Disorders33 citations Open access
Semantic Scholar
A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19
Cristina Valencia-Sanchez, D. Wingerchuk
2020Multiple Sclerosis and Related Disorders33 citations Open access
Semantic Scholar
Alterations in Aquaporin-4-IgG Serostatus in 986 Patients: A Laboratory-Based Longitudinal Analysis
M. Majed, Cristina Valencia Sanchez, J. Bennett, J. Fryer +11 more
2023Annals of Neurology32 citations Open access
Semantic Scholar
Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder
D. Wingerchuk, I. Zhang, A. Kielhorn, M. Royston +6 more
2021Neurological Therapeutics32 citations Open access
Semantic Scholar
Cerebral enhancement in MOG antibody-associated Disease
P. Elsbernd, L. Cacciaguerra, K. Krecke, John Chen +12 more
2023Journal of Neurology Neurosurgery & Psychiatry31 citations
Semantic Scholar
Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders
H. Abboud, Andrea Salazar-Camelo, Naveen George, S. Planchon +54 more
2021Journal of Neurology30 citations Open access
Semantic Scholar
A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder
A. Berthele, M. Levy, D. Wingerchuk, S. Pittock +5 more
2023Frontiers in Neurology25 citations Open access
Semantic Scholar
Frequency of Asymptomatic Optic Nerve Enhancement in a Large Retrospective Cohort of Patients With Aquaporin-4+ NMOSD
Shailee Shah, P. Morris, Marina Buciuc, Deena A. Tajfirouz +8 more
2022Neurology21 citations Open access
Semantic Scholar
Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD
B. A. Cree, J. Bennett, H. Kim, B. Weinshenker +16 more
2021Multiple Sclerosis18 citations Open access
Semantic Scholar
Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients With Myelin Oligodendrocyte Glycoprotein IgG-Associated Disorders.
Amy Kunchok, John J. Chen, Ruba S. Saadeh, D. Wingerchuk +3 more
2020JAMA Neurology18 citations Open access
Semantic Scholar
Emerging Targeted Therapies for Neuromyelitis Optica Spectrum Disorders
Cristina Valencia-Sanchez, D. Wingerchuk
2020BioDrugs15 citations
Semantic Scholar
Serum Neurofilament to Magnetic Resonance Imaging Lesion Area Ratio Differentiates Spinal Cord Infarction From Acute Myelitis.
Elia Sechi, S. Mariotto, A. McKeon, K. Krecke +9 more
2021Stroke14 citations Open access
Semantic Scholar
The spectrum of acute cardiopulmonary events associated with multiple sclerosis exacerbations
Cristina Valencia-Sanchez, B. Goodman, J. Carter, D. Wingerchuk
2019Multiple Sclerosis14 citations
Semantic Scholar
Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum
B. Weinshenker, D. Wingerchuk, Ari J. Green, J. Bennett +15 more
2023Multiple Sclerosis12 citations Open access
Semantic Scholar
What is the Role of Tumor-treating Fields in Newly Diagnosed Glioblastoma?
Abbie S. Ornelas, A. Porter, Akanksha Sharma, Molly G. Knox +3 more
2019The Neurologist12 citations
Semantic Scholar
Understanding Treatment Decisions in Neuromyelitis Optica Spectrum Disorder: A Global Clinical Record Review with Patient Interviews
Ju-Hong Min, M. Capobianco, C. Welsh, Patrícia Lobo +5 more
2023Neurological Therapeutics10 citations Open access
Semantic Scholar
Aligning payer and provider strategies with the latest evidence to optimize clinical outcomes for patients with neuromyelitis optica spectrum disorder.
D. Wingerchuk, B. Weinshenker, Dana McCormick, S. Barron +2 more
2022Journal of Managed Care & Specialty Pharmacy9 citations
Semantic Scholar
Eculizumab in Asian patients with anti-aquaporin-IgG-positive neuromyelitis optica spectrum disorder: A subgroup analysis from the randomized phase 3 PREVENT trial and its open-label extension.
H. Kim, I. Nakashima, S. Viswanathan, Kai-Chen Wang +11 more
2021Multiple Sclerosis and Related Disorders9 citations Open access
Semantic Scholar
Characterization of Disease Severity and Stability in NMOSD: A Global Clinical Record Review with Patient Interviews
M. Capobianco, M. Ringelstein, C. Welsh, Patrícia Lobo +5 more
2023Neurological Therapeutics8 citations Open access
Semantic Scholar
Does High Cerebral Microbleed Burden Increase the Risk of Intracerebral Hemorrhage After Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke?
Karissa N. Arca, B. Demaerschalk, Diana Almader-Douglas, D. Wingerchuk +1 more
2019The Neurologist8 citations
Semantic Scholar
Systematic Review Investigating Relationship Between Neuromyelitis Optica Spectrum Disorder (NMOSD) and Vaccination (P1.2-003)
A. Vanood, D. Wingerchuk
2019Neurology7 citations
Semantic Scholar
A Double-masked, Placebo-controlled Study with Open-label Period to Evaluate the Efficacy and Safety of Inebilizumab in Adult Subjects with Neuromyelitis Optica Spectrum Disorders–Top line efficacy and safety results (Plen02.001)
B. Cree, J. Bennett, H. Kim, B. Weinshenker +15 more
2019Neurology6 citations
Semantic Scholar
Are Postprocedural Blood Pressure Goals Associated With Clinical Outcome After Mechanical Thrombectomy for Acute Ischemic Stroke?
Benzion Blech, B. Chong, K. Sands, D. Wingerchuk +3 more
2019The Neurologist6 citations
Semantic Scholar
Interleukin-6 Receptor Blockade for Relapse-Prevention in MOGAD
A. Vilaseca, P. Bilodeau, Georgios Gakis, A. Savransky +53 more
2026JAMA Neurology4 citations Open access
Semantic Scholar
Is Intravenous Immunoglobulin Effective in Reducing the Risk of Mortality and Morbidity in Neuroinvasive West Nile Virus Infection?
Amir A. Mbonde, M. Grill, E. Harahsheh, Lisa A. Marks +2 more
2022The Neurologist4 citations
Semantic Scholar
Is Autologous Stem Cell Transplantation a Safe and Effective Alternative to Whole Brain Radiation as Consolidation Therapy in Patients With Primary Central Nervous System Lymphoma?
David Gritsch, M. Mrugala, Lisa A. Marks, Kartik Mangipudi +3 more
2021The Neurologist4 citations
Semantic Scholar
Is Noninvasive Vagus Nerve Stimulation a Safe and Effective Alternative to Medication for Acute Migraine Control?
Benzion Blech, Amaal J. Starling, Lisa A. Marks, D. Wingerchuk +1 more
2020The Neurologist4 citations
Semantic Scholar
Disease-modifying therapies should be stopped in NMOSD patients in remission – Commentary
D. Wingerchuk
2019Multiple Sclerosis4 citations Open access
Semantic Scholar
PACTRIMS 2022
Jin Bi, Ying Fu, Jae-Won Hyun, Yeseul Kim +210 more
2023Multiple Sclerosis3 citations
Semantic Scholar
In Patients With Melanoma Brain Metastases, Is Combination Immune Checkpoint Inhibition a Safe and Effective First-Line Treatment? A Critically Appraised Topic
David Gritsch, M. Mrugala, Lisa A. Marks, D. Wingerchuk +1 more
2022The Neurologist3 citations
Semantic Scholar
Pharmacokinetic/pharmacodynamic properties of eculizumab support established efficacy in patients with NMOSD: findings from the phase 3 PREVENT study
A. Berthele, C. Oreja-Guevara, Jacqueline Palace, D. Wingerchuk +7 more
20203 citations
Semantic Scholar
Psychiatric Comorbidities Cluster Early After Onset in MOGAD: A Cross-Sectional Comparative Study with MS and NMOSD
Moritz A. Niederschweiberer, Ç. Bakır, Nisa Vorasoot, Laura Cacciaguerra +15 more
2026Journal of Neurology Neurosurgery & Psychiatry2 citations Open access
Semantic Scholar
Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder
A. Dinoto, L. Cacciaguerra, K. Krecke, J. Chen +8 more
2024Neurology(R) neuroimmunology & neuroinflammation2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Pittock×28
Invite
S. Pittock — researcher profile on SciRah
B. Weinshenker×20
Invite
B. Weinshenker — researcher profile on SciRah
K. Fujihara×16
Invite
K. Fujihara — researcher profile on SciRah
R. Marignier×14
Invite
R. Marignier — researcher profile on SciRah

×13

Invite

H. Kim — researcher profile on SciRah

Invite

J. Bennett — researcher profile on SciRah

Invite

Dewei She — researcher profile on SciRah

Invite

G. Cutter — researcher profile on SciRah

Invite

M. Levy — researcher profile on SciRah

Invite

O. Aktas — researcher profile on SciRah

Invite

E. Katz — researcher profile on SciRah

Jacqueline Palace×9

Invite

Jacqueline Palace — researcher profile on SciRah